NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-040-2012-0-CN-33 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen CN DIV 201910555422.8 Pending
NIDA E-199-2015-0-US-04 Method and Apparatus for the Capture of Intra-cellular Activity US CON 16/450,895 11627907 Issued PDF
NLM E-111-2016-8-US-04 Novel CRISPR Enzymes And Systems US CON 16/450,852 Pending
NLM E-111-2016-8-US-03 Novel CRISPR Enzymes And Systems US CON 16/450,825 Pending
NLM E-111-2016-8-US-02 Novel CRISPR Enzymes And Systems US CON 16/450,699 Pending
NCI E-135-2018-0-JP-01 METHOD AND APPARATUS FOR TESTING NEAR INFRARED-PHOTOIMMUNOTHERAPY TREATMENT JP DIV 2023-030862 Pending
NCI E-135-2018-0-JP-03 METHOD AND APPARATUS FOR TESTING NEAR INFRARED-PHOTOIMMUNOTHERAPY TREATMENT JP National Stage 2021-520095 Pending
NCI E-291-2014-0-US-09 Method For Purifying Antibody Using PBS US CON 16/447,439 Abandoned
NCI E-115-2017-0-US-07 Azaindenoisoquinoline Compounds and Uses Thereof US National Stage 16/471,945 Pending
NCI E-135-2018-0-PCT-02 METHOD AND APPARATUS FOR TESTING NEAR INFRARED-PHOTOIMMUNOTHERAPY TREATMENT PCT PCT PCT/US2019/038097 Expired
NCI E-014-2017-0-US-06 HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR FLT3 AND USES THEREOF US National Stage 16/471,485 11236171 Issued PDF
NLM E-111-2016-7-EP-09 Novel CRISPR Enzymes And Systems EP DIV 19180795.7 Pending
NCI E-227-2006-5-US-20 PREVENTION OF TISSUE ISCHEMIA AND RELATED METHODS US DIV 16/443,415 11254735 Issued PDF
NCI E-495-2013-0-IE-01 Anti-Human Papillomavirus 16 E6 T Cell Receptors IE EP 19180239.6 Issued
NCI E-495-2013-0-IT-01 Anti-Human Papillomavirus 16 E6 T Cell Receptors IT EP 19180239.6 Issued
NCI E-495-2013-0-GB-01 Anti-Human Papillomavirus 16 E6 T Cell Receptors GB EP 19180239.6 Issued
NCI E-495-2013-0-FR-01 Anti-Human Papillomavirus 16 E6 T Cell Receptors FR EP 19180239.6 Issued
NCI E-495-2013-0-DE-01 Anti-Human Papillomavirus 16 E6 T Cell Receptors DE EP 19180239.6 Issued
NCI E-495-2013-0-EP-10 Anti-Human Papillomavirus 16 E6 T Cell Receptors EP DIV 19180239.6 Issued
NCI E-495-2013-0-ES-01 Anti-Human Papillomavirus 16 E6 T Cell Receptors ES EP 19180239.6 Issued
NCI E-060-2018-0-PCT-02 CANCER TREATMENT METHODS PCT PCT PCT/US2019/037204 Expired
NCI E-062-2018-0-PCT-02 METHODS OF TREATING HBV PCT PCT PCT/US2019/037184 Expired
NICHD E-026-2019-0-PCT-02 POLYPEPTIDES, NUCLEIC ACID MOLECULES, COMPOSITIONS, AND RELATED METHODS PCT PCT PCT/US2019/037169 Expired
NCI E-250-2016-0-US-04 METHODS OF PREPARING AN ISOLATED OR PURIFIED POPULATION OF THYMIC EMIGRANT CELLS AND MEHTODS OF TREATMENT USING SAME US National Stage 16/468,890 Pending
NIAAA E-282-2012-1-US-09 CANNABINOID RECEPTOR MEDIATING COMPOUNDS US CON 16/438,850 Abandoned
NHGRI E-044-2013-0-JP-15 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin JP DIV 2019-109410 Pending
NCI E-250-2016-0-EP-03 METHODS OF PREPARING AN ISOLATED OR PURIFIED POPULATION OF THYMIC EMIGRANT CELLS AND METHODS OF TREATMENT USING SAME EP National Stage 17825696.2 Issued
NCI E-291-2012-0-CN-23 M971 Chimeric Antigen Receptors CN DIV 201910500128.7 Issued
NIAID E-174-2017-1-US-06 Protection Of Calves By A Prefusion-stabillze Bovine RSV Vaccine US National Stage 16/468,174 11084850 Issued PDF
NEI E-162-2016-0-US-08 RPGR GENE THERAPY FOR RETINITIS PIGMENTOSA US CON 16/436,521 11045558 Issued PDF
NIAID E-124-2018-0-PCT-02 NEW COMPOSITIONS AND DETECTION METHODS FOR ONCHOCERCA VOLVULUS INFECTION PCT PCT PCT/US2019/036382 Expired
NCI E-021-2015-0-EP-09 Anti-CD70 Chimeric Antigen Receptors EP DIV 19178931.2 Issued
NCI E-021-2015-0-CH-47 Anti-CD70 Chimeric Antigen Receptors CH EP 19178931.2 Issued
NCI E-021-2015-0-GB-48 Anti-CD70 Chimeric Antigen Receptors GB EP 19178931.2 Issued
NCI E-021-2015-0-IT-42 Anti-CD70 Chimeric Antigen Receptors IT EP 19178931.2 Issued
NCI E-021-2015-0-DK-39 Anti-CD70 Chimeric Antigen Receptors DK EP 19178931.2 Issued
NCI E-021-2015-0-DE-41 Anti-CD70 Chimeric Antigen Receptors DE EP 19178931.2 Issued
NCI E-021-2015-0-FR-40 Anti-CD70 Chimeric Antigen Receptors FR EP 19178931.2 Issued
NCI E-021-2015-0-BE-38 Anti-CD70 Chimeric Antigen Receptors BE EP 19178931.2 Issued
NCI E-021-2015-0-NL-43 Anti-CD70 Chimeric Antigen Receptors NL EP 19178931.2 Issued
NCI E-021-2015-0-SE-46 Anti-CD70 Chimeric Antigen Receptors SE EP 19178931.2 Issued
NCI E-021-2015-0-NO-44 Anti-CD70 Chimeric Antigen Receptors NO EP 19178931.2 Issued
NCI E-021-2015-0-ES-45 Anti-CD70 Chimeric Antigen Receptors ES EP 19178931.2 Issued
NCI E-169-2016-0-EP-05 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS EP National Stage 17 808 241.8 Issued
NCI E-169-2016-0-ES-09 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS ES EP 17 808 241.8 Issued
NCI E-169-2016-0-CH-07 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS CH EP 17 808 241.8 Issued
NCI E-169-2016-0-GB-11 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS GB EP 17 808 241.8 Issued
NCI E-169-2016-0-NL-14 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS NL EP 17 808 241.8 Issued
NCI E-169-2016-0-IE-12 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS IE EP 17 808 241.8 Issued
NCI E-169-2016-0-IT-13 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS IT EP 17 808 241.8 Issued